Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Viatris is a global healthcare company dedicated to improving patient health. It offers a broad portfolio of medicines, including generics, biosimilars, and established brands, to promote worldwide access to pharmaceuticals. The company develops and distributes high-quality therapeutic solutions for various medical conditions.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Viatris is scheduled to report its next quarterly earnings on 11/09/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Viatris last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at 0.69 USD.
Across its last 3 earnings reports, Viatris stock moved by ±6.7% on average the following day. The largest reaction was +9% on 05/07/2026; 1 of 3 reactions were positive.
Viatris has beaten analyst EPS estimates in 3 of its last 3 evaluated quarters (beat rate: 100%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 3 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.